NEW RECOMMENDATIONS FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE ROLE OF METHOTREXATE

Autor: Evgeniy L Nasonov, D E Karateev, N V Chichasova

Publikováno v: Научно-практическая ревматология, Vol 52, Iss 1, Pp 8-26 (2014)

In our previous publication, we reported the main provisions of the new EULAR recommendations (2013) and discussed some debating points of RA pharmacotherapy that require further research. The purpose of this article is to review the present-day know

Externí odkaz: https://doaj.org/article/394a883b1a3544698a6b101fa5d0101c

P136 Efficacy and safety of olokizumab in a phase III trial in patients with moderately to severely active RA inadequately controlled by TNF-α inhibitor therapy

Autor: Michael E. Luggen, Evgeniy L Nasonov, Sergey Grishin, Eugen Feist, Elena Korneva, Saeed Fatenejad, Mikhail Samsonov

Publikováno v: Rheumatology. 60

Background/Aims Olokizumab (OKZ) is a new humanised monoclonal antibody targeting IL-6. Here we present the results of the phase III study of OKZ in anti-TNF-IR patients. Methods Patients with moderately to severely active RA who had previously faile

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::077e50bf22933e6c1b2ffb282ddad694
https://doi.org/10.1093/rheumatology/keab247.132

Imatinib mesylate use in refractory eosinophilic granulomatosis with polyangiitis: a literature review and a case report

Autor: Mikhail Y. Volkov, Evgeniy A. Naryshkin, Evgeniy L. Nasonov, Tatiana M. Novoselova, Tatiana V. Beketova

Publikováno v: Clinical Rheumatology. 37:1729-1735

Recent advances in pharmacology have greatly expanded the drug repertoire for treatment of anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare multisystemic disorder, a t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2cf10ba9b3519624cb384a4c6afb054
https://doi.org/10.1007/s10067-018-4018-1

Clinical And Morphological Improvement Of Lupus Nephritis Treated With Rituximab

Autor: Yaroslav B Khrennikov, Evgeniy L Nasonov, Sergey Soloviev, S G Radenska-Lopovok, Anna V Torgashina, Ekaterina V Nikolaeva, Maria E Tsanyan

Publikováno v: Folia Medica, Vol 56, Iss 4, Pp 245-252 (2014)

Aim: TO assess the effects of rituximab (RTM) therapy on clinical and morphologic activity of lupus nephritis (LN). Material and methods: The study included 45 patients with confirmed diagnosis of systemic lupus erythematosus (SLE), unaffected by pre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca83736739d55adf402e658f53de2574
https://pubmed.ncbi.nlm.nih.gov/26444353

Liver transplantation in a patient with primary antiphospholipid syndrome and Budd-Chiari syndrome.

Autor: Reshetnyak TM; Tatiana M Reshetnyak, Natalia V Seredavkina, Maria A Satybaldyeva, Evgeniy L Nasonov, VA Nasonova Research Institute of Rheumatology, Kashirskoye Shosse, Moscow 115522, Russian Federation., Seredavkina NV; Tatiana M Reshetnyak, Natalia V Seredavkina, Maria A Satybaldyeva, Evgeniy L Nasonov, VA Nasonova Research Institute of Rheumatology, Kashirskoye Shosse, Moscow 115522, Russian Federation., Satybaldyeva MA; Tatiana M Reshetnyak, Natalia V Seredavkina, Maria A Satybaldyeva, Evgeniy L Nasonov, VA Nasonova Research Institute of Rheumatology, Kashirskoye Shosse, Moscow 115522, Russian Federation., Nasonov EL; Tatiana M Reshetnyak, Natalia V Seredavkina, Maria A Satybaldyeva, Evgeniy L Nasonov, VA Nasonova Research Institute of Rheumatology, Kashirskoye Shosse, Moscow 115522, Russian Federation., Reshetnyak VI; Tatiana M Reshetnyak, Natalia V Seredavkina, Maria A Satybaldyeva, Evgeniy L Nasonov, VA Nasonova Research Institute of Rheumatology, Kashirskoye Shosse, Moscow 115522, Russian Federation.

Publikováno v: World journal of hepatology [World J Hepatol] 2015 Sep 08; Vol. 7 (19), pp. 2229-36.